Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | FPR2 | P25090 | 1/20 | 0.63 |
| ▸ | MTOR | P42345 | 1/20 | 0.63 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.63 |
| ▸ | MYLK | Q15746 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.62 |
| ▸ | THPO | P40225 | 2/20 | 0.62 |
| ▸ | APEX1 | P27695 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dansyl Ethylenediamine SCHEMBL30497055 | 1.00 | CYP3A4 (0.63) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL8488157 | 0.92 | HDAC4 (0.65) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL5384708 | 0.91 | HDAC4 (0.67) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL17312330 | 0.89 | HDAC4 (0.69) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL29729303 | 0.89 | HDAC4 (0.69) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL6361662 | 0.89 | HDAC4 (0.69) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL107807 | 0.89 | HDAC4 (0.69) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL107806 | 0.89 | HDAC4 (0.69) | CYP3A4CYP1A2CYP2C19CYP2D6CYP2C9 | |
| SCHEMBL2639212 | 0.89 | HDAC4 (0.61) | CYP1A2CYP2C19KDM4EHSD17B10HDAC4 | |
| SCHEMBL4126957 | 0.88 | HDAC4 (0.71) | HDAC4HDAC10HDAC6HDAC5EDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023137518-A1 | PLATINUM COMPLEXES | Western Sydney University (AU) | 2023-07-27 | — | — | WO | claimed |
| US-10768111-B2 | Fluorescent supramolecular biosensor and preparation method thereof | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2020-09-08 | — | — | US | claimed |
| WO-2015033743-A1 | METHOD FOR PREPARING LABELED SUGAR CHAIN SAMPLE | 住友ベークライト株式会社 (JP) | 2015-03-12 | — | — | WO | claimed |
| US-20110089033-A1 | METHOD OF PREPARING SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD OF ANALYZING SUGAR CHAIN | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-04-21 | — | — | US | claimed |
| EP-2295962-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | Sumitomo Bakelite Co., Ltd. (JP) | 2011-03-16 | — | — | EP | claimed |
| WO-2009150834-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | 住友ベークライト株式会社 (JP) | 2009-12-17 | — | — | WO | claimed |
| US-7605146-B2 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2009-10-20 | — | — | US | claimed |
| US-20020077456-A1 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2002-06-20 | — | — | US | claimed |
| EP-1199312-A2 | Process for producing an amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | claimed |
| JP-2003448-A | — | — | None | — | — | JP | disclosed |
| JP-8105888-A | — | — | None | — | — | JP | disclosed |
| EP-4724110-A1 | PROCESS FOR PREPARING ANTIBODY-DRUG CONJUGATES WITH IMPROVED HOMOGENEITY | WUXI XDC SINGAPORE PRIVATE LIMITED (SG) | 2026-04-15 | — | — | EP | disclosed |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2026-02-10 | — | — | US | disclosed |
| EP-4646595-A1 | PEPTIDE SEQUENCER | Oregon Health & Science University (US) | 2025-11-12 | — | — | EP | disclosed |
| US-5196576-A | Medical imaging of liver tissue | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1993-03-23 | — | — | US | disclosed |
| US-5138039-A | Diagnosis, therapy | NIHON MEDI-PHYSICS CO., LTD (JP) | 1992-08-11 | — | — | US | disclosed |
| EP-0365627-A4 | CATALYTIC HYBRIDIZATION SYSTEMS FOR THE DETECTION OF NUCLEIC ACID SEQUENCES BASED ON THEIR ACTIVITY AS COFACTORS IN CATALYTIC REACTIONS IN WHICH A COMPLEMENTARY LABELED NUCLEIC ACID PROBE IS CLEAVED | — | 1990-10-10 | — | — | EP | disclosed |
| EP-0365627-A1 | CATALYTIC HYBRIDIZATION SYSTEMS FOR THE DETECTION OF NUCLEIC ACID SEQUENCES BASED ON THEIR ACTIVITY AS COFACTORS IN CATALYTIC REACTIONS IN WHICH A COMPLEMENTARY LABELED NUCLEIC ACID PROBE IS CLEAVED. | UNIV IOWA RES FOUND (US) | 1990-05-02 | — | — | EP | disclosed |
| JP-H023448-A | FLUORESCENT ACRYLAMIDE COMPOUND | SEIKO INSTR INC | 1990-01-09 | — | — | JP | disclosed |
| WO-1989009284-A1 | CATALYTIC HYBRIDIZATION SYSTEMS FOR THE DETECTION OF NUCLEIC ACID SEQUENCES BASED ON THEIR ACTIVITY AS COFACTORS IN CATALYTIC REACTIONS IN WHICH A COMPLEMENTARY LABELED NUCLEIC ACID PROBE IS CLEAVED | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1989-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077456-A1 | Process for producing an amide compound | NAAA, ACMSD, CPS1 | CYP3A4 892/4885CYP1A2 1673/4885CYP2C19 1792/4885 |
| US-10768111-B2 | Fluorescent supramolecular biosensor and preparation method thereof | NOD2, CACYBP, CALCOCO2 | CYP3A4 4530/4885CYP1A2 4841/4885CYP2C19 4546/4885 |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | FUT7, FUT4, SIGLEC7 | CYP3A4 2860/4885CYP1A2 4270/4885CYP2C19 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.